Medicine & TechnologyA new HIV vaccine triggered low levels of a rare type of neutralizing antibodies among a small group of people who participated in a 2019 clinical trial. Find out more about it in this article.
Epstein-Barr virus links to multiple sclerosis, as virus-fighting antibodies mistakenly attack brain and spinal cord proteins. Read the article to learn more.
Antibodies sprayed into the nostrils of rats resulted in healing brain damage from stroke, which may be due to the drug passing through the nerves. Read the article to learn more.
The World Health Organization (WHO) declares the Omicron subvariant XBB.1.5 as the most transmissible COVID-19 variant after accounting for 41% of the cases in the country. Read the article to learn more.
Research reveals that linDNA COVID-19 vaccine may protect cats and other animals from coronavirus. Read and learn about this and human-to-animal COVID spread.
Researchers describe a new way of developing a more durable, highly effective COVID-19 vaccine that works against all variants. Read the article for more details.
Researchers developed an approach to detecting antibodies using nanoparticles. Ow helpful is this to the prevention of COVID-19 transmission? Read to know more.
A shocking photo of two breast milk bags with different colors showed how moms could pass antibodies to their babies after being infected with the Omicron variant to improve the immunity of their newborns.
Recent research from Massachusetts General Hospital showed vaccination for women during pregnancy led to more lasting levels of antibodies in infants, when compared to infants born to unvaccinated mothers infected with COVID-19.
New research claims that vaccinated women transfer their SARS-CoV-2 antibodies to their babies through breastfeeding, potentially activating passive immunity against the virus.
Experts from Cedars-Sinai recently discovered contributing evidence on how COVID-19 infection triggers the production of aggressive, self-attacking antibodies.
The mRNA vaccine is among the two COVID-19 vaccines that offered more than 90% protection from SARS-CoV-2 to prevent symptomatic infection. So how does it become so effective in protecting against the virus?